+
Site Tour

Trending Controversies | AV Valves

Scientific session covering critical debates shaping the future of AV Valves interventions. Faculty and audience delve into three pivotal questions: How much should we optimize medical therapy before indicating TEER? Should we delay reparability to enhance patient outcomes? And, in the realm of TTVI, should we prioritize repair or replacement? Thought-provoking exchange of ideas and insights.

FIND OUT MORE ON AV VALVES SUMMIT 2024:

Watch on Demand videos

Related Videos

AV Valves Summit 2024 | Closing of Day 2

TriClip - AVVS 1 year 1 minute Tricuspid - Video

Case Parade | Mitral focus

Navigating the Anatomy | Tricuspid focus

Review the Trends | Tricuspid focus

LAAO Summit - LAAO in a patient at risk of DRT

MitraClip™ Patient Story: Scott

LAAO Summit - Decoding DRT patient factors

EACTS 2022: Tendyne™ vs on-pump MVR

Echo course tricuspid TEER – patient selection

EuroEcho 2021: Tricuspid regurgitation: The Evidence

LAAO Summit 2023: Stroke severity

AV Valves Summit 2024 | Opening of Day 2

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

Clinical insights: Intaglio™

ACC 2023: COAPT™ trial

Amplatzer™ Septal Occluder (ASO) brochure

PCRLV 2022: bRIGHT 30 days

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit - Pre-procedural imaging

Case Transmission | Tricuspid focus

TriClip - AVVS 1 year 1 minute Tricuspid - Video

Pre-term PDA cases

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline